Abstract

トランスポーター阻害に基づく糖尿病創薬：SGLT2阻害薬

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor ... Jenny E Blau
The Journal of clinical endocrinology and metabolism | VOL. 100
Simeon I Taylor, et. al.Simeon I Taylor ... Jenny E Blau
18 Jun 2015
SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes
Katherine Donnan ... Lakshman Segar
European Journal of Pharmacology: Molecular Pharmacology | VOL. 846
Katherine Donnan, et. al.Katherine Donnan ... Lakshman Segar
11 Jan 2019
Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition.
Michael A Weintraub ... Dazhi Liu
Breast cancer research and treatment | VOL. 203
Michael A Weintraub, et. al.Michael A Weintraub ... Dazhi Liu
13 Sep 2023
Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials.
Shiwen Yang ... Na Su
Frontiers in Pharmacology | VOL. 14
Shiwen Yang, et. al.Shiwen Yang ... Na Su
13 Jun 2023
View more papers

More From: Drug Delivery System

Paper Title
Journal
Date
Author
ジノプロストン腟内留置用製剤（プロウペス<sup>Ⓡ</sup>）の臨床成績・特性・適正使用・最近の報告
Daisuke Mikami ... Atsushi Nakano
Drug Delivery System | VOL. 39
Daisuke Mikami, et. al.Daisuke Mikami ... Atsushi Nakano
25 Mar 2024
「Drug Delivery System VOL.39 NO.1 JAN. 2014」訂正のお知らせ
-
Drug Delivery System | VOL. 39
--
25 Mar 2024
The importance of academic research to the parallel development of drug discovery science and regulatory science
Masatoshi Hori
Drug Delivery System | VOL. 39
Masatoshi HoriMasatoshi Hori
25 Mar 2024
University startups and their fundraising
Noriyuki Kawata
Drug Delivery System | VOL. 39
Noriyuki KawataNoriyuki Kawata
25 Mar 2024
View more papers